Prostaglandin F stimulation of cyclooxygenase-2 promoter activity by the FPB prostanoid receptor

Hiromichi Fujino, John W Regan

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

We have recently shown that the FPB prostanoid receptor activates β-catenin signaling through the activation of Rho in human embryo kidney (HEK)-293 cells stably expressing the FPB receptors. We now report that the FPB receptor can stimulate cyclooxygenase-2 promoter activity and may, therefore, regulate the expression of cyclooxygenase-2. This stimulation of cyclooxygenase-2 promoter activity is blocked by pretreatment with an inhibitor of Rho, but not with an inhibitor of protein kinase C (PKC). Potential up regulation of cyclooxygenase-2 expression by the FPB receptor would establish a positive feedback loop that would drive β-catenin signaling and could be involved in cancer.

Original languageEnglish (US)
Pages (from-to)39-41
Number of pages3
JournalEuropean Journal of Pharmacology
Volume465
Issue number1-2
DOIs
StatePublished - Mar 28 2003

Fingerprint

Dinoprost
Cyclooxygenase 2
Prostaglandins
Catenins
Protein Kinase C
Up-Regulation
Embryonic Structures
Kidney
Neoplasms

Keywords

  • β-catenin signaling
  • Cyclooxygenase-2
  • FP prostanoid receptor

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Prostaglandin F stimulation of cyclooxygenase-2 promoter activity by the FPB prostanoid receptor. / Fujino, Hiromichi; Regan, John W.

In: European Journal of Pharmacology, Vol. 465, No. 1-2, 28.03.2003, p. 39-41.

Research output: Contribution to journalArticle

@article{da86ab73149448b6bfa44489f1f00959,
title = "Prostaglandin F2α stimulation of cyclooxygenase-2 promoter activity by the FPB prostanoid receptor",
abstract = "We have recently shown that the FPB prostanoid receptor activates β-catenin signaling through the activation of Rho in human embryo kidney (HEK)-293 cells stably expressing the FPB receptors. We now report that the FPB receptor can stimulate cyclooxygenase-2 promoter activity and may, therefore, regulate the expression of cyclooxygenase-2. This stimulation of cyclooxygenase-2 promoter activity is blocked by pretreatment with an inhibitor of Rho, but not with an inhibitor of protein kinase C (PKC). Potential up regulation of cyclooxygenase-2 expression by the FPB receptor would establish a positive feedback loop that would drive β-catenin signaling and could be involved in cancer.",
keywords = "β-catenin signaling, Cyclooxygenase-2, FP prostanoid receptor",
author = "Hiromichi Fujino and Regan, {John W}",
year = "2003",
month = "3",
day = "28",
doi = "10.1016/S0014-2999(03)01485-7",
language = "English (US)",
volume = "465",
pages = "39--41",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Prostaglandin F2α stimulation of cyclooxygenase-2 promoter activity by the FPB prostanoid receptor

AU - Fujino, Hiromichi

AU - Regan, John W

PY - 2003/3/28

Y1 - 2003/3/28

N2 - We have recently shown that the FPB prostanoid receptor activates β-catenin signaling through the activation of Rho in human embryo kidney (HEK)-293 cells stably expressing the FPB receptors. We now report that the FPB receptor can stimulate cyclooxygenase-2 promoter activity and may, therefore, regulate the expression of cyclooxygenase-2. This stimulation of cyclooxygenase-2 promoter activity is blocked by pretreatment with an inhibitor of Rho, but not with an inhibitor of protein kinase C (PKC). Potential up regulation of cyclooxygenase-2 expression by the FPB receptor would establish a positive feedback loop that would drive β-catenin signaling and could be involved in cancer.

AB - We have recently shown that the FPB prostanoid receptor activates β-catenin signaling through the activation of Rho in human embryo kidney (HEK)-293 cells stably expressing the FPB receptors. We now report that the FPB receptor can stimulate cyclooxygenase-2 promoter activity and may, therefore, regulate the expression of cyclooxygenase-2. This stimulation of cyclooxygenase-2 promoter activity is blocked by pretreatment with an inhibitor of Rho, but not with an inhibitor of protein kinase C (PKC). Potential up regulation of cyclooxygenase-2 expression by the FPB receptor would establish a positive feedback loop that would drive β-catenin signaling and could be involved in cancer.

KW - β-catenin signaling

KW - Cyclooxygenase-2

KW - FP prostanoid receptor

UR - http://www.scopus.com/inward/record.url?scp=0037470759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037470759&partnerID=8YFLogxK

U2 - 10.1016/S0014-2999(03)01485-7

DO - 10.1016/S0014-2999(03)01485-7

M3 - Article

VL - 465

SP - 39

EP - 41

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1-2

ER -